FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912388172> ?p ?o ?g. }

• W2912388172 endingPage "e393" @default.
• W2912388172 startingPage "e386" @default.
• W2912388172 abstract "Objectives: Although the effect of antihypertensive agents on sepsis has been studied, evidence for survival benefit was limited in the literature. We investigated differences in sepsis-related outcomes depending on the antihypertensive drugs given prior to sepsis in patients with hypertension. Design: Population-based cohort study. Setting: Sample cohort Database of the National Health Insurance Service from 2003 to 2013 in South Korea. Patients: Patients over 30 years old who were diagnosed with sepsis after receiving hypertension treatment. Interventions: None. Measurements and Main Results: Primary outcomes, 30-day and 90-day mortality rates, were analyzed for differences among three representative antihypertensive medications: angiotensin- converting enzyme inhibitors or angiotensin II receptor blockers, calcium channel blockers, and thiazides. In total, 4,549 patients diagnosed with hypertension prior to hospitalization for sepsis were identified. The 30-day mortality was significantly higher among patients who did not receive any medications within 1 month before sepsis (36.8%) than among patients who did (32.0%; p < 0.001). The risk for 90-days mortality was significantly lower in prior angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker users (reference) than in other drug users (odds ratio, 1.27; 95% CI, 1.07–1.52). There was no difference in the risk for 30-day and 90-day mortality depending on whether calcium channel blockers or thiazides were used. Use of calcium channel blockers was associated with a decreased risk for inotropic agent administration, compared with those of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers (odds ratio, 1.23; 95% CI, 1.05–1.44) and thiazides (odds ratio, 1.33; 95% CI, 1.12–1.58). Conclusions: In patients with sepsis, lower mortality rate was associated with prior use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers not with use of calcium channel blockers or thiazides. The requirement of inotropic agents was significantly lower in prior use of calcium channel blockers, although the survival benefits were not prominent." @default.
• W2912388172 created "2019-02-21" @default.
• W2912388172 creator A5029925322 @default.
• W2912388172 creator A5037295746 @default.
• W2912388172 creator A5049834556 @default.
• W2912388172 creator A5051107618 @default.
• W2912388172 creator A5057464621 @default.
• W2912388172 creator A5061053245 @default.
• W2912388172 creator A5087160550 @default.
• W2912388172 date "2019-05-01" @default.
• W2912388172 modified "2023-10-03" @default.
• W2912388172 title "Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study*" @default.
• W2912388172 cites W1547854467 @default.
• W2912388172 cites W1751629383 @default.
• W2912388172 cites W1965680545 @default.
• W2912388172 cites W1972100184 @default.
• W2912388172 cites W2011888431 @default.
• W2912388172 cites W2021967857 @default.
• W2912388172 cites W2029310154 @default.
• W2912388172 cites W2033375786 @default.
• W2912388172 cites W2043811298 @default.
• W2912388172 cites W2051717751 @default.
• W2912388172 cites W2071272265 @default.
• W2912388172 cites W2085147947 @default.
• W2912388172 cites W2086927244 @default.
• W2912388172 cites W2091309724 @default.
• W2912388172 cites W2103943763 @default.
• W2912388172 cites W2104134630 @default.
• W2912388172 cites W2125574730 @default.
• W2912388172 cites W2132355007 @default.
• W2912388172 cites W2135634526 @default.
• W2912388172 cites W2146234846 @default.
• W2912388172 cites W2156689182 @default.
• W2912388172 cites W2165037395 @default.
• W2912388172 cites W2280404143 @default.
• W2912388172 cites W2444120931 @default.
• W2912388172 cites W2574997063 @default.
• W2912388172 cites W2591460015 @default.
• W2912388172 cites W2727039071 @default.
• W2912388172 cites W2749609607 @default.
• W2912388172 cites W2768165371 @default.
• W2912388172 cites W2796112888 @default.
• W2912388172 cites W4232887860 @default.
• W2912388172 doi "https://doi.org/10.1097/ccm.0000000000003654" @default.
• W2912388172 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30688717" @default.
• W2912388172 hasPublicationYear "2019" @default.
• W2912388172 type Work @default.
• W2912388172 sameAs 2912388172 @default.
• W2912388172 citedByCount "26" @default.
• W2912388172 countsByYear W29123881722019 @default.
• W2912388172 countsByYear W29123881722020 @default.
• W2912388172 countsByYear W29123881722021 @default.
• W2912388172 countsByYear W29123881722022 @default.
• W2912388172 countsByYear W29123881722023 @default.
• W2912388172 crossrefType "journal-article" @default.
• W2912388172 hasAuthorship W2912388172A5029925322 @default.
• W2912388172 hasAuthorship W2912388172A5037295746 @default.
• W2912388172 hasAuthorship W2912388172A5049834556 @default.
• W2912388172 hasAuthorship W2912388172A5051107618 @default.
• W2912388172 hasAuthorship W2912388172A5057464621 @default.
• W2912388172 hasAuthorship W2912388172A5061053245 @default.
• W2912388172 hasAuthorship W2912388172A5087160550 @default.
• W2912388172 hasConcept C104849204 @default.
• W2912388172 hasConcept C126322002 @default.
• W2912388172 hasConcept C156957248 @default.
• W2912388172 hasConcept C201903717 @default.
• W2912388172 hasConcept C27016395 @default.
• W2912388172 hasConcept C2778384902 @default.
• W2912388172 hasConcept C2780192228 @default.
• W2912388172 hasConcept C2908647359 @default.
• W2912388172 hasConcept C2908929049 @default.
• W2912388172 hasConcept C71924100 @default.
• W2912388172 hasConcept C72563966 @default.
• W2912388172 hasConcept C84393581 @default.
• W2912388172 hasConcept C99454951 @default.
• W2912388172 hasConceptScore W2912388172C104849204 @default.
• W2912388172 hasConceptScore W2912388172C126322002 @default.
• W2912388172 hasConceptScore W2912388172C156957248 @default.
• W2912388172 hasConceptScore W2912388172C201903717 @default.
• W2912388172 hasConceptScore W2912388172C27016395 @default.
• W2912388172 hasConceptScore W2912388172C2778384902 @default.
• W2912388172 hasConceptScore W2912388172C2780192228 @default.
• W2912388172 hasConceptScore W2912388172C2908647359 @default.
• W2912388172 hasConceptScore W2912388172C2908929049 @default.
• W2912388172 hasConceptScore W2912388172C71924100 @default.
• W2912388172 hasConceptScore W2912388172C72563966 @default.
• W2912388172 hasConceptScore W2912388172C84393581 @default.
• W2912388172 hasConceptScore W2912388172C99454951 @default.
• W2912388172 hasIssue "5" @default.
• W2912388172 hasLocation W29123881721 @default.
• W2912388172 hasLocation W29123881722 @default.
• W2912388172 hasOpenAccess W2912388172 @default.
• W2912388172 hasPrimaryLocation W29123881721 @default.
• W2912388172 hasRelatedWork W1991854388 @default.
• W2912388172 hasRelatedWork W1995604303 @default.
• W2912388172 hasRelatedWork W2002610357 @default.
• W2912388172 hasRelatedWork W2022842708 @default.
• W2912388172 hasRelatedWork W2027472844 @default.

• next